UBS OCONNOR LLC - IDERA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$220,000,00050,0000.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,094,745$9,563,0000.59%
WALL STREET ASSOCIATES 400,000$1,236,0000.35%
Palo Alto Investors LP 1,257,748$3,886,0000.22%
Baker Brothers Advisors 6,983,107$21,578,0000.18%
NATIXIS 3,148,916$9,730,0000.16%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$1,149,0000.12%
MYCIO WEALTH PARTNERS, LLC 200,000$618,0000.11%
HOLLENCREST CAPITAL MANAGEMENT 177,570$549,0000.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 701,815$2,169,0000.07%
CARL DOMINO INC 29,137$90,0000.07%
View complete list of IDERA PHARMACEUTICALS INC shareholders